Senior commercial executive with 31 years of bio-pharmaceutical and device experience focused on phase IIb – phase IV commercial access, pricing, reimbursement and health policy strategy development and launch plan preparation/execution. Highly collaborative with leadership teams, providing empowering market access insights and strategies that ultimately impact commercial direction leading to successful results. Directly creating and executing value proposition, pricing and channel actions supporting the overall brand/product strategy and market access priorities in multiple disease states including neuroscience, cardiology, rheumatology, gastroenterology, dermatology, oncology, allergy and immunology and infectious disease. Expertise and Skill Sets:* Global & US Market Access - Commercial, Medicare and Medicaid * Strategic Planning* U.S. Public Health Policy Development * Government Relations - Federal & State * Startup Commercial Build Out * Value Proposition Development/ HECON * Pricing Strategy* Reimbursement - CPT and HCPCS * Channel Strategy* National Sales Leadership - Field Sales & National Accounts* Patient Access & HUB Operations * Analytics and Forecasting * Formulary and Contract Negotiations * Specialty Pharmacy Distribution* New Product Development and Launch Expertise * Government Contracting – VA, DOD & PHS * Product Life Cycle Management * Strategic Alliance Development
Listed skills include Healthcare, Medicaid, Pharmaceutical Industry, Managed Care, and 31 others.